UnitedHealth Group Inc (NYSE:UNH) – Analysts at Piper Jaffray Companies decreased their Q1 2020 earnings estimates for UnitedHealth Group in a research note issued to investors on Tuesday, April 16th. Piper Jaffray Companies analyst S. James now forecasts that the healthcare conglomerate will earn $3.98 per share for the quarter, down from their previous estimate of $4.10. Piper Jaffray Companies also issued estimates for UnitedHealth Group’s Q2 2020 earnings at $3.96 EPS, Q3 2020 earnings at $4.40 EPS and Q4 2020 earnings at $4.37 EPS.
Several other brokerages have also commented on UNH. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, February 27th. Credit Suisse Group reaffirmed a “buy” rating and issued a $310.00 price target on shares of UnitedHealth Group in a research note on Friday, February 8th. Oppenheimer boosted their price objective on UnitedHealth Group from $300.00 to $305.00 and gave the company an “outperform” rating in a report on Wednesday, January 16th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, March 19th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a report on Tuesday, January 15th. One analyst has rated the stock with a sell rating, one has issued a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $291.56.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.60 by $0.13. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The business had revenue of $60.30 billion for the quarter, compared to analyst estimates of $59.72 billion. During the same quarter in the prior year, the company posted $3.04 EPS. The company’s quarterly revenue was up 9.2% on a year-over-year basis.
In other UnitedHealth Group news, Director Richard T. Burke sold 5,000 shares of the company’s stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $245.01, for a total transaction of $1,225,050.00. Following the sale, the director now owns 182,372 shares in the company, valued at approximately $44,682,963.72. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Gail R. Wilensky sold 2,930 shares of the company’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $253.39, for a total value of $742,432.70. Following the sale, the director now owns 64,726 shares in the company, valued at approximately $16,400,921.14. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,930 shares of company stock worth $4,587,133. 0.87% of the stock is owned by company insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of UNH. Oregon Public Employees Retirement Fund increased its holdings in shares of UnitedHealth Group by 50,446.5% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 53,349,795 shares of the healthcare conglomerate’s stock valued at $214,000 after acquiring an additional 53,244,249 shares during the last quarter. Norges Bank purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $2,343,175,000. BlackRock Inc. increased its holdings in shares of UnitedHealth Group by 3.1% in the 4th quarter. BlackRock Inc. now owns 69,831,381 shares of the healthcare conglomerate’s stock valued at $17,396,391,000 after acquiring an additional 2,123,417 shares during the last quarter. Rehmann Capital Advisory Group increased its holdings in shares of UnitedHealth Group by 26,088.2% in the 3rd quarter. Rehmann Capital Advisory Group now owns 1,723,185 shares of the healthcare conglomerate’s stock valued at $6,477,000 after acquiring an additional 1,716,605 shares during the last quarter. Finally, FMR LLC increased its holdings in shares of UnitedHealth Group by 1.9% in the 4th quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock valued at $16,063,258,000 after acquiring an additional 1,232,189 shares during the last quarter. Institutional investors own 86.68% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Market Capitalization – What it Means for Investors
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.